Panacea Life Sciences Holdings Inc (OTC: PLSH) is a hemp-derived cannabidiol (CBD) consumer products company that formulates, manufactures, and sells CBD-based supplements, topicals, and pet products. Revenue comes from direct-to-consumer e-commerce sales, retail channel distribution, and business-to-business bulk ingredient sales. The filing excerpts provided do not contain sufficient operational or financial detail to characterize market position, segment revenue percentages, customer counts, named competitors, or capital structure. Based solely on the 10-K filed April 1, 2024 (accession 000149315224012107), the company operates in the hemp-derived CBD product space and is subject to SEC reporting requirements as a smaller reporting company. Additional material business details, including fiscal year revenue figures, geographic footprint, leadership, and founding history, are not supported by the excerpts provided and are omitted here.

Source: SEC 10-K, filed 2024-04-01

Industry: Medicinal Chemicals & Botanical Products Peers: Kaya Holdings Inc CANNABIS STRATEGIC VENTURES RespireRx Pharmaceuticals Inc. Earth Science Tech Inc Johnson & Johnson